Psychology ideas
97 innovation ideas derived from recent Psychology research — AI-assessed, source-linked, with live prototypes.
Research themes in Psychology
Cited overviews of the research behind these ideas, and the opportunities still open.
Psychedelic-Assisted Psychotherapy
The use of serotonergic agonists (psilocybin, MDMA) combined with psychological support to treat treatment-resistant depression, PTSD, and alcohol use disorder.
- Psychedelic Therapy Protocol & Integration Platform
- Recovery Language Monitor for Therapeutic Communities
- Telehealth MBCT Program for Geographically Isolated Patients
87 papers · 34 ideas
Psychological Well-being and Organizational Stress
The intersection of individual psychological health, organizational dynamics, and the impact of societal/cultural standards on mental well-being.
- Knowledge-Hiding Motive Diagnostic for HR
- Threat-Alert Perception Pretest for Public Safety Agencies
- Org-Design Resilience Stress-Test
19 papers · 23 ideas
All Psychology ideas
An app module that uses short drills to fix two common English pronunciation mistakes.
Backed by 2 papers
A quick speaking test for migrants to find those stuck on the same pronunciation errors for months.
A high-utility clinical SaaS that solves a documented regulatory and scientific gap in psychedelic trial fidelity, moving beyond simple certification into a data-capture tool for sponsors.
Backed by 9 papers
A high-impact, specialized diagnostic tool that addresses a systemic bias in special education referrals with a clear, evidence-backed mechanism.
Backed by 2 papers
A highly specialized preclinical assay service targeting a specific, evidence-backed pharmacological gap in the psychedelic drug development pipeline.
Backed by 8 papers
Ready-to-use lesson packs that help adult English learners fix specific pronunciation mistakes.
A compliance-driven SDK with a real regulatory tailwind and a focused product concept, but it rests on a single 30-year-old theoretical source with no modern digital-context efficacy data, and faces a crowded incumbent RG-tooling market it doesn't clearly differentiate from.
A well-timed, low-friction entry point for a high-demand demographic, though it lacks significant novelty compared to existing female-focused screeners in the catalog.
Backed by 2 papers
A focused, high-utility coaching tool that leverages LLM-based discourse analysis to improve parental scaffolding of early literacy, with a clear B2B2C distribution path through established early-childhood organizations.
Backed by 8 papers
A low-friction, high-utility clinical instrument that converts a documented behavioral trend into an actionable EHR data point for youth mental health.
Backed by 2 papers
A well-reasoned clinician-adjunct tool that leverages a proven delivery mechanism (EMI) to target a specific cognitive pathology in gambling addiction.
Backed by 2 papers
A searchable database of old Irish asylum records to help people find ancestors who disappeared from other records.
A log for student counselors and supervisors to track problems and fixes during their clinical training.
A highly focused, evidence-backed screening tool that transforms academic peer-status research into a practical caseload management tool for school counselors.
Backed by 3 papers
An app that turns a supervisor's spoken stories about clinical problems into polished articles for journals.
An app that creates a personalized list of questions for patients to ask their doctor.
Backed by 2 papers
A review service that fixes biased or confusing questions in surveys before they are sent out.
Backed by 2 papers
A highly focused, low-friction intervention that targets the specific social friction of school re-entry by equipping the peer group rather than just the patient.
Backed by 3 papers
A tablet check-in for mothers in hospital wards to identify who needs the most emotional or social support.
A high-utility B2B audit service that converts a documented, severe demographic disparity in AI mental health helpfulness into a critical pre-ship compliance and quality metric.
Backed by 2 papers
A focused, psychometrically-backed screening tool for university student success programs that identifies students lacking reading metacognition for early intervention.
A visual mapping tool for therapists to chart a client's personal beliefs and track how they change over time.
Backed by 2 papers
A well-reasoned clinical program that smartly differentiates itself from depression clinics by targeting the high-risk post-detox window for severe AUD patients.
Backed by 11 papers
A tracker for parents of sick children that triggers a request for professional help when care hours get too high.
Technically feasible telehealth-MBCT product in a crowded market, but built almost entirely on a single case-study letter to the editor, making the evidence base too thin to justify the specific population claim.
A high-incentive B2B play targeting disability insurers, though it faces significant regulatory hurdles and a lack of direct evidence linking clinical recovery to workforce reentry.
Backed by 7 papers
A highly focused, low-friction decision tool that translates complex academic research into a practical clinical workflow for school counselors.
Backed by 2 papers
A well-reasoned digital therapeutic that leverages a specific research finding on mindfulness heterogeneity to personalize relapse prevention, though it faces a high regulatory bar for clinical claims.
Backed by 2 papers
A niche clinical tool that digitizes validated MBCT assessment frameworks, though it faces a significant evidence contradiction regarding the predictive power of mindfulness profiles.
Backed by 3 papers
A tool for newsrooms that scans political speeches for patterns of leader-worship and aggressive rhetoric.
Backed by 2 papers
A high-impact, specialized tool that transforms a fragmented clinical process into a structured therapeutic product with a clear commercial wedge.
Backed by 2 papers
A targeted feature for e-textbook platforms that uses a validated inventory to personalize reading prompts, though it is a derivative application of an existing screener idea.
A timely B2B infrastructure play that solves the 'implementation gap' for psychedelic medicine by providing the operational and safety standards required for clinical adoption.
Backed by 16 papers
ClearBet addresses a real clinical gap with a sensible CBT-based approach, but it leans on a single 1992 source with no independent corroboration, enters a field with existing specialized apps, and its feature list dilutes what could be a sharp wedge.
A low-complexity clinical checklist that provides immediate utility for psychiatrists transitioning to psychedelic-assisted therapy, though it lacks a strong technical moat.
Backed by 11 papers
A niche compliance tool that pivots from the impossible goal of full XAI to a 'disclosure of limits' framework, well-aligned with the EU AI Act's focus on documentation over technical transparency.
Backed by 4 papers
A clinically-integrated screening tool for pediatric body image risks that replaces universal BMI thresholds with culturally and gender-calibrated risk norms.
Backed by 7 papers
A pragmatic B2B play that monetizes the 'how-to' of psychedelic therapy, cleverly bypassing drug distribution risks while targeting a high-demand clinical gap.
Backed by 8 papers
Short training modules for counselors where every lesson is linked directly to a peer-reviewed study.
A timely, high-demand professional certification for a newly legalized medical market, though it faces significant operational hurdles regarding clinical residency placements.
Backed by 24 papers
A niche historical-pharmacopeia database with a coherent concept but weak evidentiary foundation, an already-served market, and no clear moat against existing natural-product and ethnopharmacology databases.
A quick classroom activity that helps teachers see how their students view learning and ability.
Backed by 2 papers
A service in Saudi Arabia that pairs mothers of sick children with experienced peer mentors.
Backed by 2 papers
A timely professional certification for clinicians to deliver psychedelic-assisted therapy, leveraging the critical gap between drug approval and practitioner readiness.
Backed by 12 papers
A scientifically grounded but explicitly paper-suggested TrkB PAM concept for non-hallucinogenic antidepressants that is technically ambitious and entering a rapidly crowding competitive space, making commercial differentiation the key risk rather than scientific rationale.
Backed by 2 papers
An interactive course that teaches voters how to spot and resist the tricks used in political propaganda.
A focused and novel location-biased pharmacology concept with real commercial upside, but the two cited papers partially contradict each other on whether 5-HT2A is necessary for plasticity at all, and achieving in-vivo selectivity for intracellular vs. surface pools of the same GPCR is a formidable unsolved chemistry problem.
Backed by 2 papers
A focused clinical tool for depression relapse prevention that leverages a proven therapeutic framework (MBCT) to solve a specific psychiatrist pain point.
A conceptually interesting shift in HR philosophy that lacks a strong technical moat and faces significant behavioral hurdles regarding employee trust.
Backed by 4 papers
A specialized diagnostic tool that identifies the gap between a student's perceived and actual reading competence by combining a validated survey with eye-tracking data.
Backed by 2 papers
A high-risk, high-reward drug discovery play targeting a specific receptor location to decouple therapeutic neuroplasticity from hallucinogenic effects.
A high-precision B2B diagnostic tool for clinical trials that converts complex fMRI data into a actionable 'plasticity score' to optimize the timing of psychedelic integration therapy.
Backed by 6 papers
A high-evidence clinical delivery model for a validated therapy, though it faces significant regulatory headwinds and low novelty relative to existing psychedelic infrastructure ideas.
Backed by 10 papers
A highly specialized diagnostic tool for a niche clinical trial market with strong scientific grounding but significant operational hurdles due to fMRI costs.
Backed by 3 papers
A high-cost, high-precision screening tool for Phase III trials that leverages fMRI biomarkers to reduce non-responder rates in psychedelic therapy.
Backed by 2 papers
A disciplined, research-backed diagnostic product for philanthropic funders that replaces vague consulting with a standardized two-layer baseline of objective conditions and subjective perceptions.
Backed by 2 papers
A pragmatic, risk-mitigated approach to scaling mental health support in crisis zones by leveraging transdiagnostic principles for lay-workers.
Backed by 2 papers
The idea is a redundant iteration of existing clinic models for psilocybin-assisted therapy, offering no distinct technical or operational innovation over previously cataloged ideas.
Backed by 12 papers
A digital tool that helps insecure workers map out what work means to them to plan better career moves.
A high-risk, high-reward clinical model for TRD that leverages strong efficacy data but faces severe regulatory headwinds and high operational overhead.
Backed by 12 papers
A low-moat pedagogical toolkit that attempts to solve a systemic psychological issue through teacher-led interventions without a clear technical or proprietary edge.
A high-efficacy clinical model for TRD that leverages specific regional legal windows, though it faces significant scaling hurdles due to high labor costs and regulatory volatility.
Backed by 10 papers
A specialized clinical decision support tool for rare metabolic disorders that leverages knowledge graphs to map causal biological pathways to targeted therapies, though it risks over-engineering by blending legacy taxonomic theories with complex multi-agent LLM architectures.
Backed by 8 papers
A high-utility therapeutic tool with a clear clinical wedge, though it faces significant technical hurdles regarding the stability of DOM-scraping on social platforms.
Backed by 2 papers
A dating app feature that gives users a reality check after long sessions to protect their self-esteem.
Backed by 2 papers
History and data packs for the sites of Ireland's 22 former district asylums.
A socially valuable but commercially weak concept that repackages well-established task-shifting practice under a common-factors frame, without a clear revenue model or defensible differentiation from existing programs.
A high-potential clinical model for treatment-resistant depression that leverages strong efficacy data, though it faces significant regulatory hurdles and high operational overhead.
Backed by 11 papers
A workshop that teaches HR and counselors how to update old theories with current scientific evidence.
Backed by 2 papers
A high-utility clinical tool that cleverly pivots from the subjective 'idealized body' problem to a technical 'digital manipulation' detection problem to support eating disorder recovery.
Backed by 6 papers
A niche B2B tool for labor organizations that transforms sociological theory into a practical decision-tree for insecure workers, though it risks being a 'workbook in an app' with limited scalability.
Backed by 2 papers
A theoretically grounded but evidence-thin pre-clinical mental health app with a genuinely novel framing that is undermined by a crowded market, an over-stacked intervention bundle, and a scattered GTM implied by naming employers, WHO, and FEMA as simultaneous buyers.
A card with questions for hourly workers to ask managers about pay and schedules during interviews.
Backed by 2 papers
A specialized software tool for automating 3D geometric morphometric analysis, bridging the gap between raw scan data and phylogenetic evolutionary insights.
Backed by 13 papers
A high-risk, high-reward pharmaceutical play that attempts to decouple the antidepressant effects of psychedelics from their hallucinogenic properties, though it faces significant oncogenic safety hurdles and direct competition from existing PAM concepts.
Backed by 10 papers
A high-potential pharmaceutical lead targeting a specific TrkB transmembrane domain to decouple antidepressant neuroplasticity from hallucinogenic effects, though it is nearly identical to existing catalog ideas.
Backed by 9 papers
A niche clinical decision-support tool that attempts to map genetic biomarkers to diseases via a causal taxonomy, though it lacks a clear technical moat and relies on a very dated conceptual framework.
Backed by 4 papers
A niche UI/UX feature for health apps that addresses a real psychological pain point, but lacks a strong standalone commercial moat or a high-value B2B incentive.
A high-acuity clinical service for treatment-resistant PTSD that leverages a proven pharmaceutical protocol, though it faces significant regulatory hurdles and high operational overhead.
Backed by 11 papers
A high-potential pharmacological approach to non-hallucinogenic plasticity, though it suffers from low novelty due to near-identical existing ideas in the catalog.
Backed by 5 papers
A niche digital humanities tool for medical historians that lacks a clear commercial buyer and relies on a tenuous leap from rare disease AI to historical text mapping.
Backed by 4 papers
A sophisticated diagnostic tool for labor organizers that moves beyond material grievances to map the psychological and narrative readiness of a workforce for mobilization.
Backed by 8 papers
A generic mental health app for a niche problem that lacks a clear B2B incentive and faces high competition from existing wellness tools.
A ready-to-use teaching module for psychology courses about the history of sexual selection.
Backed by 2 papers
A niche academic tool for medical historians and informatics researchers that lacks a clear commercial buyer and a compelling 'why now' for clinical application.
Backed by 5 papers
A philosophically-grounded HR facilitation tool with a real pain-point but no empirical foundation, no clear wedge, and a deeply academic framing that would repel rather than attract enterprise buyers.
A vague, over-scoped wellness application that attempts to digitize complex psychotherapeutic principles without a concrete product mechanism.
A scalable, evidence-based training model for lay-workers that leverages transdiagnostic healing principles to address the global mental health gap.
A high-risk, high-reward pharmacological play targeting intracellular receptors to decouple neuroplasticity from hallucinogenic effects, though it faces immense delivery hurdles.
Backed by 5 papers
A consulting-led certification program that attempts to operationalize complex social theory into HR practice, but lacks a concrete product mechanism and relies on a tenuous leap from academic philosophy to corporate training.
Backed by 3 papers
A conceptually ambitious but practically fragmented tool that attempts to merge 18th-century taxonomic philosophy with modern proteomics, lacking a clear commercial buyer.
Backed by 5 papers
A historically-framed disease ontology built on a single 18th-century text with no modern research corroboration, entering a space already occupied by mature etiological ontologies (SNOMED-CT, HPO, Disease Ontology) and CDS platforms, leaving little clear differentiation or investable wedge.
A high-concept philosophical application of Judith Butler's ethics that lacks a concrete product mechanism and faces severe cultural resistance in corporate HR environments.
An audit service that checks if mental health laws are being used for their intended purpose.
Backed by 2 papers
A low-moat service idea that translates a basic sociological observation into a generic consulting model without a scalable product mechanism.
The idea attempts to modernize a 19th-century taxonomic approach to pharmacology, but it essentially describes a database that already exists in modern pharmacopeias and drug-target interaction databases.
A well-intentioned wellness tool that suffers from extreme technical infeasibility and a lack of a clear B2B buyer.